Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Star

1915.00
-1.21%
ICICI Direct
CDMO influence keeps growing- in numbers and aspirations : Laurus Labs operates in the segment of generic APIs & FDFs (formulations), custom synthesis (CDMO) and biotechnology. Major focus in APIs is...
Laurus Labs Ltd. has an average target of 1715.00 from 4 brokers.
More from Laurus Labs Ltd.
Recommended